Ziprasidone Mesylate Injection, Powder, Lyophilized, For Solution
Product Images NDC 43598-061

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ziprasidone Mesylate (NDC 43598-061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

FDA Label Image

Label (Label)

PremierProRx is a medication used for intramuscular or intravenous use only. Each 1 mL of the medication (when reconstituted) includes ziprasidone mesylate, which is equal to 20 mg of ziprasidone and 47 mg of methanesulfonic acid solubilized by 204 mg of sulfobutylether β-cyclodextrin sodium (SBECD). The drug is only for single-use and must be reconstituted to 20 mg/mL using sterile water for injection. Shake the medication until it is completely dissolved, and it will create a colorless to a pale pink solution. The usual dosage is specified in the accompanying prescribing information. Store PremierProRx at 20°C to 25°C to protect it from light.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.